Cardio Diagnostics Holdings, Inc. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cardio Diagnostics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
  • Cardio Diagnostics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.41M, a 2.44% increase year-over-year.
  • Cardio Diagnostics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.39M, a 3.8% decline year-over-year.
  • Cardio Diagnostics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$7.24M, a 59.2% decline from 2022.
  • Cardio Diagnostics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$4.55M, a 633% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.24M -$2.69M -59.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$4.55M -$3.93M -633% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$620K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.